MŽMaja Životić

Maja Životić

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maja Životić has a total of 134 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Shifts in Diagnostic Practices and Histopathological Profiles of Renal Tumors During the COVID-19 Pandemic: A Single-Center Retrospective Study

    by Gorana Nikolić, Uroš Jovanović, Danijel Milivojević, Milena Jovanović, Jovan Jevtić, Marina Perić, Voin Brković, Darko Jovanović, Jelena Stefanović, Jadranka Miletić Vukajlović, et al.

    Background: The COVID-19 pandemic disrupted healthcare services worldwide, potentially affecting diagnostic and therapeutic approaches to renal tumors. This study aimed to compare the demographic characteristics, diagnostic procedures, and histopathological features of renal lesions before and during the pandemic. Methods: This retrospective, single-center study included 1780 renal lesions submitted for histopathological examination at a tertiary referral institution in Serbia between September 2016 and September 2023. Cases were divided into pre-pandemic (n = 809) and pandemic (n = 971) groups. Demographic characteristics, tumor laterality, diagnostic and surgical procedures, histopathological diagnoses, and selected pathological parameters of different types of renal cell carcinomas (RCCs) were compared. Results: The distribution of diagnostic and surgical procedures differed significantly between the two periods (p < 0.001), with the proportion of percutaneous core needle biopsies increasing from 5.3% to 11.3%. The overall distribution of histopathological diagnoses also differed significantly (p < 0.001), primarily reflecting lower proportions of low-grade RCC (4.2% vs. 1.8%; adjusted p = 0.0347) and other benign epithelial and mesenchymal tumors (4.8% vs. 2.3%; adjusted p = 0.0489). Among the major RCC subtypes, no statistically significant differences were observed in nuclear grade distribution (p = 0.069), pathological tumor stage (p = 0.358), or tumor size (p = 0.412). Patients in the pandemic period were slightly older than those in the pre-pandemic period (median age: 63 vs. 62 years; p = 0.040). Conclusions: The pandemic period was associated with significant changes in the distribution of diagnostic procedures and selected histopathological diagnoses, without a demonstrable shift toward more advanced pathological stages among the evaluated RCC cases. These findings highlight the importance of considering changes in diagnostic pathways and case selection when interpreting renal tumor characteristics during periods of healthcare disruption.

  • Complementary Diagnostic Value of ZEB1 and CK7 in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma

    by Jelena Filipović, Ivan Soldatović, Maja Životić, Duško Dunđerović, Jovan Jevtić, Gorana Nikolić, Jadranka M. Vukajlović, Sanja Radojević-Škodrić

    Renal oncocytoma (RO) is a benign renal epithelial tumor that may closely mimic chromophobe renal cell carcinoma (chRCC), particularly in limited biopsy specimens. In addition, the expanding spectrum of oncocytic renal neoplasms further complicates the differential diagnosis. This study included 251 renal epithelial tumors, of which 250 were included in statistical analyses. The cohort comprised RO, chRCC, papillary RCC, clear cell RCC, collecting duct carcinoma, multilocular cystic renal neoplasm of low malignant potential, and a single case of eosinophilic vacuolated tumor (EVT). Tissue microarrays were constructed from formalin-fixed, paraffin-embedded tissue, and immunohistochemical expression of ZEB1, CK7, CD117, AMACR, CD10, GATA3, SDHB, Cathepsin K, and FH was assessed using H-score analysis. Statistical evaluation included 1-way ANOVA, receiver operating characteristic (ROC) curve analysis, and binary logistic regression. RO demonstrated significantly higher ZEB1 expression compared with all other tumor subtypes ( P <0.001), while ZEB1 expression was absent in chRCC. The single EVT case, excluded from statistical analysis, also showed no ZEB1 expression. In contrast, CK7 expression was highest in chRCC and minimal in RO. ROC analysis demonstrated excellent diagnostic performance for both markers (ZEB1 AUC=0.941; CK7 AUC=0.945), and combined analysis showed strong discriminatory power, with an overall classification accuracy of 95.5%. ZEB1 represents a promising complementary marker in the differential diagnosis of RO and chRCC. In combination with CK7, it provides a simple and practical immunohistochemical approach that may improve diagnostic accuracy, particularly in limited biopsy specimens. Further validation across the expanding spectrum of oncocytic renal neoplasms is warranted.

  • Open Access

    Combined Apocynin and Novokinin Treatment Attenuates Renal Damage and Reduces KIM-1 Expression in a Model of Ischemic AKI

    by Milan Ivanov, Nevena Mihailović-Stanojević, Una-Jovana Vujačić, Danijela Karanović, Djurdjica Jovović, Maja Životić, Sanjin Kovacevic, Jelena Nešović-Ostojić, Zoran Miloradović

    Ischemia–reperfusion injury (IRI) of the kidney represents a serious medical issue with complex pathological mechanisms that remain poorly elucidated. The development of ischemic acute kidney injury (AKI) may be mediated by NADPH oxidase and angiotensin II type 2 receptors. The aim of our study was to explore the effects of novokinin (NOV), angiotensin II type 2 receptor (AT2R) agonist and apocynin (APO), an NADPH oxidase inhibitor, on kidney structure and function, as well as the level of oxidative stress in spontaneously hypertensive rats (SHR) with induced IRI. Animals were randomly assigned into five experimental groups: the Sham-operated animals (SHAM) group, the AKI group, and AKI groups receiving APO, NOV, or their combination. Slight improvements in renal function were noted across all treated groups; however, only the combined action of APO + NOV led to a significant decrease in kidney injury molecule-1 (KIM-1) levels and markedly reduced oxidative stress compared with the control AKI group. Our results demonstrate that additively targeting NADPH oxidase and AT2R provides new insights in comparison to individual treatments. These findings suggest a potentially promising new therapeutic strategy for managing IRI and improving outcomes in critically ill patients with AKI.

  • Open Access

    Olive Leaf Extract Added to Losartan Treatment Improved Klotho/Wnt/β-Catenin Signaling in Hypertensive Rats with Focal Segmental Glomerulosclerosis

    by Danijela Karanović, Nevena Mihailović-Stanojević, Milan Ivanov, Una-Jovana Vujačić, Jelica Grujić-Milanović, Maja Životić, Dragana Dekanski, Djurdjica Jovović, Zoran Miloradović

    The downregulation of Klotho in renal injury predicts the progression of chronic kidney disease (CKD). Klotho acts as an antagonist of the Wnt/β-catenin pathway, which is involved in the pathogenesis of proteinuria, glomerulosclerosis and tubulointerstitial fibrosis. We investigated whether losartan (L, angiotensin II type-1 receptor blocker) alone or combined with synthetic (tempol, T) or natural antioxidants (olive leaf extract, O) could alter Klotho/Wnt4/β-catenin signaling, thus reducing fibrosis and slowing the progression of focal segmental glomerulosclerosis (FSGS) in spontaneously hypertensive rats (SHR). The rats were divided into five groups. The control rats received a vehicle. The other groups received adriamycin (2 mg/kg, i.v., twice in a 3-week interval) for FSGS induction. Treatments with L, L+T and L+O (10, 10 + 100 and 10 + 80 mg/kg/day, respectively) were administered by gavage during six weeks. In the kidneys of model rats, Klotho and Wnt4 were downregulated, whereas β-catenin and fibronectin levels were increased compared with the control group. L+T did not alter Klotho, Wnt4 or fibronectin levels, while it further increased β-catenin. In contrast, L+O improved Klotho, and reduced β-catenin and fibronectin levels, although it increased PAI-1. The L+O combination reduced proteinuria more efficiently than L and decreased renal injury close to control levels. Although these findings indicate that combined treatment of losartan and olive leaf extract is promising in slowing the progression of the experimental FSGS, further clinical studies are needed to confirm its favorable outcomes and safety in CKD patients.


  • Open Access

    IgA Nephropathy in Native Kidneys: Oxford and Banff Classifications Reveal Distinct Profiles and Predict Outcomes in Pediatric and Adult Patients

    by Danijel Milivojević, Gorana Nikolić, Björn Tampe, Maja Pecić, Snežana Babac, Dušan Paripović, Gordana Miloševski Lomić, Voin Brković, Marko Baralić, Aleksandar Janković, et al.

    IgA nephropathy is the most common primary glomerulonephritis, with pathohistological changes described by the Oxford classification, while the Banff classification is used in transplant pathology. This study included 253 patients with IgA nephropathy in native kidneys, divided into the pediatric (n = 105) and adult (n = 148) groups. It aimed to examine clinical, and Oxford and Banff morphological parameters in relation to age, correlations of clinical data with pathohistological parameters, and predictors of the disease outcome. Pediatric patients more frequently presented with macroscopic hematuria, while adults showed higher urea and creatinine levels, and lower eGFR. Examining Oxford classification parameters, chronic glomerular and tubulointerstitial lesions were more common in adults. Banff parameters revealed more frequent chronically active glomerular, inflammatory, chronic tubulointerstitial, and vascular lesions in adults. All inflammatory, chronic tubulointerstitial, and vascular parameters correlated with serum urea levels, eGFR and CKD stage in adults, while less frequent in pediatric patients. Tubulointerstitial Oxford and Banff parameters were strong predictors of CKD and proteinuria progression in children, while such predictors were fewer in adults; segmental glomerulosclerosis predicted hematuria progression in adults. Banff parameters (cg, t, ti, i, i-IFTA, ptc, cv), not in Oxford classification, significantly predict outcomes and are recommended for incorporation into IgA nephropathy reports.


  • Open Access

    Coexisting Congenital Mesoblastic Nephroma and Lissencephaly: Unique Case Report with Pathological Analysis and Its Clinical Significance

    by Hristina Zakić, Olivera Kontić Vučinić, Jelena Stamenković, Jovan Jevtić, Milena Perišić Mitrović, Maja Životić

    Background: Congenital mesoblastic nephroma represents 3–10% of all pediatric renal tumors. With the advancement of ultrasound diagnostics and magnetic resonance imaging, the diagnosis of this renal neoplasm is increasingly being established prenatally and at birth. It usually presents as a benign tumor, but it can severely affect pregnancy outcomes, contributing to perinatal morbidity and mortality. Lissencephaly belongs to a rare category of neurodevelopmental disorders marked by the absence of a substantial reduction in the typical folds and grooves in the cerebral cortex. The prognosis for patients with lissencephaly is extremely poor, carrying with it a high mortality rate. Case Presentation: We present a case of congenital mesoblastic nephroma (CMN) diagnosed with polyhydramnios at 28 weeks of gestation, which led to preterm delivery at 29 weeks and a fatal outcome for the newborn. Histopathological examination confirmed the diagnosis of CMN along with fetal pachygyria/lissencephaly. The aim of this study is to point out the characteristics and unique correlation between CMN and lissencephaly, and to illustrate the histopathological features of CMN and lissencephaly through an educational example derived from our presented index case. To the best to our knowledge, the association of CMN with lissencephaly has not been described in the literature so far. Conclusions: Outlining the prenatal progression of CMN and the outcome of pregnancies involving fetal CMN and lissencephaly, this case underscores the importance of comprehensive ultrasound examinations, including central nervous system evaluation, to identify potential coexisting anomalies and refine prenatal diagnostic practices.


  • Open Access

    Morphological changes in kidneys and clinical presentation in patients with primary and secondary membranous nephropathy

    by Danijel Milivojević, Maja Pecić, Gorana Nikolić, Ana Mioljević, Voin Brković, Marko Baralić, Petar Đurić, Aleksandar Janković, Sanja Radojević-Škodrić, Maja Životić

    Introduction/Aim: Membranous nephropathy (MN) typically presents as nephrotic syndrome and may be idiopathic (primary MN, pMN) or occur secondary to other diseases (secondary MN, sMN). Given the differing therapeutic approaches, this study aimed to compare clinical and pathohistological parameters between patients with pMN and sMN. Methods: Through a retrospective analysis of kidney biopsy samples diagnosed at the Institute of Pathology, Faculty of Medicine, Belgrade, between 2011 and 2023, 99 patients with membranous nephropathy were identified. These patients were divided into two groups: patients with pMN (n = 44) and patients with sMN (n = 55). Clinical and pathohistological parameters (by optical and immunofluorescence microscopy) were compared among study participants. Results: While males more frequently suffered from MN, females more frequently had sMN (p = 0.036). Haematuria was more common in subjects with sMN (p = 0.009). Proteinuria values were significantly higher among patients with pMN (p = 0.018), related to a significantly greater decrease in serum total protein values in them (p = 0.011). Endocapillary proliferation was significantly more frequent among those with sMN (p = 0.032). Marked positivity of several immunofluorescent markers was significantly more common in subjects with sMN: IgA, IgM, C1q, κ-chains, and λ-chains (p < 0.05). Conclusion: Females are more commonly affected by sMN. Characteristics of sMN include presence of haematuria, endocapillary hypercellularity and immunofluorescence positivity for markers not seen in pMN (IgA, IgM, C1q), while characteristics of pMN include significantly higher levels of proteinuria, accompanied by significantly reduced serum protein values.

  • Open Access

    Immunohistochemical and histochemical marker expression in the differential diagnosis of renal cell tumors

    by Milica Višić, Minya Karac, Maja Životić, Duško Dunđerović, Jovan Jevtić, Sanja Radojević-Škodrić, Jelena Filipović

    Introduction: The most common renal cell tumors (RCTs) include clear cell renal cell carcinoma (ccRCC), ccRCC with eosinophilic component (ccRCCe), papillary RCC (pRCC), chromophobe RCC (chRCC), and renal oncocytoma (RO). Due to overlapping morphological features, immunohistochemical (IHC) and histochemical (HC) markers are crucial for accurate differential diagnosis. Materials and Methods: This retrospective study included 237 patients. Tissue microarrays were manually prepared and stained with H&E, CAIX, AMACR, CD10, CD117, CK7, PRMT1, ZEB1, and Hale's colloidal iron. Semiquantitative analysis was performed using a BX53 microscope and scanned with a Leica-Aperio AT2 scanner. Results: Significant gender differences were observed (p = 0.0003), with a higher proportion of males in ccRCC, ccRCCe, and pRCC, while RO was more common in females. Tumor size varied significantly (p = 0.0041); ccRCCe tumors were the largest (73.1 mm), and RO the smallest (48.3 mm). Compared to ccRCC, ccRCCe showed lower PRMT1, ZEB1, and CAIX expression and higher CD10 expression. pRCC showed high AMACR expression. RO was strongly positive for PRMT1, ZEB1, and CD117, and negative for CK7, CD10, and Hale's stain. Conversely, chRCC was negative for PRMT1 and ZEB1, but positive for CK7, CD117, and Hale's stain. Conclusion: The following IHC panel may improve diagnostic accuracy: PRMT1+/ZEB1+/CK7-/Halefor RO; CK7+/PRMT1-/ZEB1-/Hale+ for chRCC; CAIX+/CD10+/AMACR-/CK7for ccRCC; and AMACR+ for pRCC. Demographic and clinicopathological differences highlight the importance of integrating clinical parameters into diagnosis and treatment planning.

  • Open Access

    Association of Congenital Mesoblastic Nephroma and Cerebral Lissencephaly/Pachygyria: Case Report and Literature Review

    by Hristina Zakic, Olivera Kontic Vucinic, Jelena Stamenkovic, Jovan Jevtić, Milena Perisic Mitrovic, Maja Zivotic

    Congenital mesoblastic nephroma represents 3 - 10 % of all pediatric renal tumors. With the advancement of ultrasound diagnostics and magnetic resonance imaging, the diagnosis of this renal neoplasm is increasingly being established prenatally and at birth. It usually presents as a benign tumor, but it can severely affect pregnancy outcomes, contributing to serious complications, perinatal morbidity and mortality. Lissencephaly belongs to a rare category of neurodevelopmental disorders marked by the absence of substantial reduction of the typical folds and grooves in the cerebral cortex. The prognosis for patients with lissencephaly is extremely poor, carryng with it a high mortality rate. The aim of this study is to point out the characteristics and unique correlation between CMN and lissencephaly, and to illustrate the histopathological features of CMN and lissencephaly through an educational example derived from our presented index case. To the best to our knowledge, the association of CMN with lissencephaly has not been decribed in the literature so far. Outlining the prenatal progression of CMN and the outcome of pregnancies involving fetal CMN and lissencephaly this case underscores the importance of comprenhesive ultrasound examionations, including central nervous system evaluation, to identify potenial coexisting anomalies and refine prenatal diagnostic practices.

  • Open Access

    Urtica dioica L. Leaf Extract Dose-Dependently Modulates Oxidative Stress in the Kidney and Exerts Anti-Fibrotic and Anti-Inflammatory Properties by the Molecular Mechanisms Independent of NRF-2 Signalization Mirroring the Effects of Losartan in SHR

    by Una-Jovana Vajic, Nevena Mihailovic-Stanojevic, Danijela Karanovic, Maja Zivotic, Milan Ivanov, Djurdjica Jovovic, Jelica Grujic-Milanovic, Zoran Miloradovic

    Previously, we confirmed systemic antihypertensive and antioxidant properties of Urtica dioica L. leaf extract (UE) in spontaneously hypertensive rats (SHR). Here, we aimed to evaluate whether UE can alter the NO and Nrf-2 signaling to prevent local oxidative stress and kidney damage in the model of essential hypertension. SHR were divided into five groups: SHRC-control, received 0.5 mL/day of water, SHR+L received 10 mg/kg/day of losartan, SHR+UE10, SHR+UE50, and SHR+UE200 received 10, 50, and 200 mg/kg/day during next 4 weeks. At the end of the experiment, urine samples were collected for albuminuria and nitrate/nitrite assessment. Mean arterial pressure (MAP) was measured, and blood samples were collected for plasma creatinine evaluation. Kidneys were analyzed for nitrate/nitrite, oxidative stress, and target molecules by biochemical, Western blot, and immunofluorescent techniques. Losartan and UE50 significantly reduced MAP, albuminuria, oxidative stress, fibroinflammatory markers, and NRF-2/CAT/SOD signaling, with a significant increase in 6-nitrotryptophan and eNOS expressions compared to control. The effects of UE showed dose dependence. Beneficial effects of UE and losartan were independent of NRF-2 signalization in SHR. Interestingly, all treatments induced the increase in 6-nitrotryptophan expression, thus further studies are needed to elucidate the mechanisms of such nitrated tryptophan.